HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Top Medical News

FDA Approves Baloxavir Marboxil Flu Drug for Children

August 12th 2022

The FDA has approved Baloxavir Marboxil (Xofluza) for children 5 years and older to treat and prevent influenza.

New CDC Guidelines Reduce Quarantine After COVID-19 Exposure

August 11th 2022

Asymptomatic individuals in low-risk settings do not have to quarantine after COVID-19 exposure, CDC says.

Omicron BA.4 and BA.5 Can’t Be Neutralized by Prior Infection

August 11th 2022

Neutralization of BA.4 and BA.5 dropped significantly for individuals who were infected with a previous strain of Omicron, even if they were also vaccinated.

Next Generation Antimalarial MAB Targets Susceptibility of P falciparum

August 11th 2022

Next generation antimalarial monoclonal antibody is three times more potent than predecessor in preventing parasitemia, stopping parasite replicating.

Langya Virus Zoonotic Spillover in Eastern China

August 10th 2022

Langya virus, a new type of henipavirus, was identified in at least 35 people in eastern China. The virus is suspected to have infected shrews before jumping to humans.

Conference Coverage
View All >>

10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups

August 9th 2022

Expanding Medicaid and reducing stigma can bolster equitable HIV PrEP access, Dr. Patrick Sullivan says.

Biktarvy Effective for HIV Patients Coinfected With Hepatitis B

August 1st 2022

At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.

Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients

July 30th 2022

After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.

The Patient Impact of CDI, Preventing Reoccurrence

June 1st 2022

A clinician discusses the disease burden of reoccurring CDI, but sees a silver lining in the new investigational therapies potentially changing the treatment paradigm for the better.

Video Interviews
View All >>
10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups
In Low-Income Communities, Pharmacists Can Play a Critical Role in Vaccine Access
Infectious Disease Virologist: “Nobody Should be Scared of Paxlovid Rebound”
Trying to Reduce AMR Through Legislative Means
Utilizing Global Surveillance to Develop a Syphilis Vaccine
A Novel Device With COVID-19 Treatment Potential
Getting Men Screened and Being Proactive About Their Health
A Potential Monkeypox Therapy?
HPV Vaccination: A Prevention Measure Against Numerous Cancers
SNG001: Synairgen's COVID-19 Antiviral for the Immunocompromised
NACCHO: Addressing Public Health’s Vital Work
The Patient Impact of CDI, Preventing Reoccurrence
The Next Big Thing in Stewardship?
Rapid Diagnostic Testing’s Impact on Timing to Optimal Therapy
Measuring the Effectiveness of a Novel Antibiotic for Patients with Nontuberculous Mycobacterial Infections
Podcasts
View All >>
Episode 6: World Hepatitis Day: Where Do We Go From Here?
ACIP Preferentially Recommends Fluzone High-Dose Influenza Vaccine for Seniors
Episode 5: “A Social and Political Pandemic”: HIV Disparities in LGBTQ+ People
Episode 4: Forging an Evolutionary Regulatory Path for Antibiotic Development
Episode 3: “We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs
Episode 2: Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Episode 1: Vaccine Inequity With Dr. Leonard Friedland
Vaccine Race: The Pfizer Vaccine with William Schaffner, MD
COVID-19 Vaccine Race: FDA Advisory Committee Meeting with Donald Alcendor, PhD
Vaccine Race: Mei Mei Hu on Developing, Researching a COVID-19 Vaccine